ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Approves NCI Plans For Organ Systems

February 5, 1988

ECG Disputes Accrual Figures Cited By DeVita, Says Numbers Are Up 17% This Year And Still Rising

July 8, 1988

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

In Brief: NCI awards center Grant to Cancer Institute of New Jersey; Researcher Win Honors

April 4, 1997

ASCO Supports Tobacco Tax Increase

March 7, 2003

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002